Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.418 EUR | -0.75% | -7.87% | -27.58% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-27.58% | 510M | |
+1.51% | 42.75B | |
+48.04% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- HC Wainwright Adjusts Price Target on Valneva SE to $26 From $22, Maintains Buy Rating